Reports for ADC Therapeutics SA
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.Find out more
Economic information
Comprehensive information about the economic situation of a company.Find out more
Payment collection information
Overview of current and past debt enforcement proceedings.Find out more
Shareholder Information
Find out which national and international companies the stock corporation you are interested in also holds shares in.Find out more
Company dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.Retrieve company dossier
About ADC Therapeutics SA
- ADC Therapeutics SA has its legal headquarters in Epalinges and is active. It is a Company limited by shares (AG) and active in the industry «Research and development».
- The management of the company ADC Therapeutics SA, entered in the trade register on the 06.06.2011, consists of 12 persons.
- The company has last modified its commercial register entry on 28.10.2025. All previous commercial register entries are available under «Notifications».
- In the commercial register the company ADC Therapeutics SA is registered under the UID CHE-461.408.645.
Management (12)
newest board members
Timothy Patrick Coughlin,
Robert Azelby,
Ameet Mallik,
Jean-Pierre Bizzari,
Viviane Rosine Françoise Beck Monges
newest authorized signatories
Timothy Patrick Coughlin,
Alison Grant,
Liliane Brügger,
Niall McConnell,
Robert Azelby
Commercial register information
Entry in the commercial register
06.06.2011
Legal form
Company limited by shares (AG)
Legal headquarters of the company
Epalinges
Commercial Registry Office
VD
Commercial register number
CH-550.1.094.173-1
UID/VAT
CHE-461.408.645
Sector
Research and development
Purpose (Original language)
La Société a pour but la recherche, le développement, la production et la vente de produits dans les domaines de la biotechnologie, de la pharmaceutique, de la technologie médicale, du diagnostic et de la thérapie ainsi que l'acquisition, la vente et l'utilisation de brevets et de licences dans ces domaines (pour but complet cf. statuts).
Auditor
Current auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| PricewaterhouseCoopers SA | Lausanne | 09.12.2015 | ||
Other company names
Past and translated company names
- ADC Therapeutics AG
- ADC Therapeutics Ltd
- ADC Therapeutics Sàrl
- 10ADC Sàrl
Branches (0)
Ownership structure
Holdings
Newest SOGC notifications: ADC Therapeutics SA
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1006469410, Commercial Registry Office Vaud, (550)
ADC Therapeutics SA, à Epalinges, CHE-461.408.645 (FOSC du 17.06.2025, p. 0/1006358479). Statuts modifiés le 23.10.2025. Augmentation ordinaire du capital-actions dans la limite de la marge de fluctuation du capital.
Nouveau capital-actions entièrement libéré:
CHF 10'087'376.96, divisé en 126'092'212 actions nominatives de CHF 0.08, avec restrictions quant à la transmissibilité selon statuts.
Publication number: HR02-1006358479, Commercial Registry Office Vaud, (550)
ADC Therapeutics SA, à Epalinges, CHE-461.408.645 (FOSC du 11.06.2025, p. 0/1006353145). Statuts modifiés le 12.06.2025. Augmentation ordinaire du capital-actions dans la limite de la marge de fluctuation du capital.
Nouveau capital-actions entièrement libéré:
CHF 9'187'376.96, divisé en 114'842'212 actions nominatives de CHF 0.08, avec restrictions quant à la transmissibilité selon statuts. L'organe de révision PricewaterhouseCoopers SA (CHE-497.306.752) a transféré son siège à Lausanne.
Publication number: HR02-1006353145, Commercial Registry Office Vaud, (550)
ADC Therapeutics SA, à Epalinges, CHE-461.408.645 (FOSC du 16.05.2025, p. 0/1006334262). Statuts modifiés le 03.06.2025. L'assemblée générale a modifié une clause statutaire relative à une augmentation conditionnelle du capital (selon décision du 24.04.2020) par décision du 03.06.2025. Pour les détails, voir les statuts. Pfisterer Thomas n'est plus administrateur;
sa signature est radiée. Coughlin Timothy Patrick, des USA, à Dallas (USA), est membre du conseil d'administration avec signature collective à deux.
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.